Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,075
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Houston TX, San Antonio TX, Dallas TX, Birmingham AL,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase3, Recruiting
Active & Responsive
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for
Solid Tumor Malignancies
Location: Houston TX, Austin TX, San Antonio TX, Dallas TX,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT06994806
Phase1, Recruiting
Active & Responsive
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
for
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm,
Location: Houston TX, St Louis MO, Atlanta GA, Tampa FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07114601
Phase1, Recruiting
Active & Responsive
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
for
Breast Cancer, Endometrial Cancer, Ovarian Cancer,
Location: Houston TX, Austin TX, San Antonio TX, Nashville TN,
Sponsor: Terremoto Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07109726
Phase1, Phase2, Recruiting
Active & Responsive
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
for
Chronic Myeloid Leukemia,
Location: Houston TX, Toronto, New York NY, The Bronx NY,
Sponsor: Enliven Therapeutics
Sex: All
Age: 18+
Code: NCT05304377
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
for
Lymphoblastic Leukemia
Location: Houston TX, San Antonio TX, Little Rock AR, Orlando FL,
Sponsor: Tanja Andrea Gruber
Sex: All
Age: 0 - 1
Code: NCT05848687
Phase1, Phase2, Recruiting
Active & Responsive
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)